MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

When Amy Seitz got pregnant with her second child last year, she knew that being 35 years old meant there was an increased chance of chromosomal disorders like Down syndrome. She wanted to be screened ...

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

People battling throat cancer may gain extra guidance on their treatment with DNA blood tests taken before and after ...

Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows. Led by researchers at NYU Langone Health and its Perlmutter Cancer ...

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, ...

Researchers at the University of California, Los Angeles have published a new blood test designed to detect multiple cancers ...

Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual ...

A new blood test analyzes DNA fragments to screen for 50 types of cancer simultaneously. The $949 Galleri test detected ...

Detecting whether osteosarcoma, a rare but aggressive bone cancer that most often affects children and adolescents, has ...